DCG International Investments Ltd. has filed a Form 144 to sell 575 shares of Grayscale Livepeer Trust (LPT), valued at approximately $1,098.25. This filing, dated October 29, 2026, highlights a significant move by the company that could impact its investment strategy and liquidity.
DCG International Investments Ltd. is a company incorporated in Delaware, with its business address listed as 3 Mill Creek Road, Pembroke. The company operates in the investment sector, focusing on various asset classes and investment vehicles.
The filing indicates that DCG International Investments intends to sell 575 shares of Grayscale Livepeer Trust, which are common securities. The shares were acquired through a privately negotiated transaction on September 24, 2021, and the approximate sale date is also noted as October 29, 2026. The filing states, "DCG International Investments Ltd" as the seller, indicating its role as an affiliate of the issuer, Grayscale Livepeer Trust.
In the past three months, DCG International Investments has been active in the market, having sold several batches of shares. Notably, the company sold 875 shares on July 30, 2026, for gross proceeds of $1,233.75, and again on July 31, 2026, for $1,198.75. This pattern of selling indicates a strategic approach to managing its holdings in Grayscale Livepeer Trust.
As this filing unfolds, it may affect various stakeholders, including investors and market analysts who track DCG International Investments and Grayscale Livepeer Trust. The sale of shares could influence perceptions of the trust's market position and investor confidence in its future performance.
The filing does not specify what happens next regarding the proceeds from this sale or any further actions by DCG International Investments Ltd.
Read Next
Workers United Files to Sell $8.4 Million in Amalgamated Stock
Carvana Co. files to sell 10 million shares of stock
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals










